US 10287355
Methods and compositions for modulating lymphangiogenesis, E.G., to treat transplant rejection, in a subject
granted A61KA61K2039/507A61K35/30
Quick answer
US patent 10287355 (Methods and compositions for modulating lymphangiogenesis, E.G., to treat transplant rejection, in a subject) held by The Regents of the University of California expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/507, A61K35/30, A61K39/3955